BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30962328)

  • 1. A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan.
    Hishinuma T; Tada T; Uchida H; Shimojima M; Kirikae T
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.
    Poirel L; Naas T; Nicolas D; Collet L; Bellais S; Cavallo JD; Nordmann P
    Antimicrob Agents Chemother; 2000 Apr; 44(4):891-7. PubMed ID: 10722487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence and spread of VIM-type metallo-β-lactamase-producing Pseudomonas aeruginosa clinical isolates in Japan.
    Hishinuma T; Uchida H; Tohya M; Shimojima M; Tada T; Kirikae T
    J Glob Antimicrob Resist; 2020 Dec; 23():265-268. PubMed ID: 33045441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina.
    Pasteran F; Faccone D; Petroni A; Rapoport M; Galas M; Vázquez M; Procopio A
    Antimicrob Agents Chemother; 2005 Jan; 49(1):474-5. PubMed ID: 15616342
    [No Abstract]   [Full Text] [Related]  

  • 5. bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital.
    Lee K; Lim JB; Yum JH; Yong D; Chong Y; Kim JM; Livermore DM
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1053-8. PubMed ID: 11897589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of the integrons of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates collected by nationwide surveillance programs across Japan.
    Mano Y; Saga T; Ishii Y; Yoshizumi A; Bonomo RA; Yamaguchi K; Tateda K
    BMC Microbiol; 2015 Feb; 15():41. PubMed ID: 25881168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons.
    Yan JJ; Hsueh PR; Lu JJ; Chang FY; Ko WC; Wu JJ
    J Antimicrob Chemother; 2006 Sep; 58(3):530-6. PubMed ID: 16816399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone.
    Arca-Suárez J; Fraile-Ribot P; Vázquez-Ucha JC; Cabot G; Martínez-Guitián M; Lence E; González-Bello C; Beceiro A; Rodríguez-Iglesias M; Galán-Sánchez F; Bou G; Oliver A
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-beta-lactamase.
    Oh EJ; Lee S; Park YJ; Park JJ; Park K; Kim SI; Kang MW; Kim BK
    J Microbiol Methods; 2003 Sep; 54(3):411-8. PubMed ID: 12842488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion.
    Samuelsen O; Toleman MA; Sundsfjord A; Rydberg J; Leegaard TM; Walder M; Lia A; Ranheim TE; Rajendra Y; Hermansen NO; Walsh TR; Giske CG
    Antimicrob Agents Chemother; 2010 Jan; 54(1):346-52. PubMed ID: 19884381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
    Er H; Altındiş M; Aşık G; Demir C
    Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of co-existing bla VIM-2 and bla NDM-1 in clinical isolates of Pseudomonas aeruginosa from India.
    Paul D; Dhar D; Maurya AP; Mishra S; Sharma GD; Chakravarty A; Bhattacharjee A
    Ann Clin Microbiol Antimicrob; 2016 May; 15():31. PubMed ID: 27154587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Pseudomonas aeruginosa clinical strains harboring the bla(VIM-2) metallo-beta-lactamase gene in Akita Prefecture, Japan.
    Yatsuyanagi J; Saito S; Ito Y; Ohta K; Kato J; Harata S; Suzuki N; Amano K
    Jpn J Infect Dis; 2004 Jun; 57(3):130-2. PubMed ID: 15218228
    [No Abstract]   [Full Text] [Related]  

  • 15. Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-{beta}-lactamase from different Italian hospitals.
    Riccio ML; Pallecchi L; Docquier JD; Cresti S; Catania MR; Pagani L; Lagatolla C; Cornaglia G; Fontana R; Rossolini GM
    Antimicrob Agents Chemother; 2005 Jan; 49(1):104-10. PubMed ID: 15616282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia.
    Crespo MP; Woodford N; Sinclair A; Kaufmann ME; Turton J; Glover J; Velez JD; Castañeda CR; Recalde M; Livermore DM
    J Clin Microbiol; 2004 Nov; 42(11):5094-101. PubMed ID: 15528701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VIM-47, a New Variant of the Autochthonous Metallo-β-Lactamase VIM-13 from the Balearic Islands in Spain.
    Zamorano L; Mulet X; Garau M; Gallegos C; Juan C; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2016 May; 60(5):3251-2. PubMed ID: 26976859
    [No Abstract]   [Full Text] [Related]  

  • 18. Metallo-beta-lactamase-producing imipenem-resistant Pseudomonas aeruginosa clinical isolates in a university teaching hospital in Malaysia: detection of IMP-7 and first identification of IMP-4, VIM-2, and VIM-11.
    Khosravi Y; Tee Tay S; Vadivelu J
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):294-6. PubMed ID: 20462725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of β-lactamases in Pseudomonas aeruginosa isolates producing metallo-β-lactamase in two Tunisian hospitals.
    Ktari S; Mnif B; Znazen A; Rekik M; Mezghani S; Mahjoubi-Rhimi F; Hammami A
    Microb Drug Resist; 2011 Mar; 17(1):25-30. PubMed ID: 21190476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the first VIM metallo-beta-lactamase-producing Pseudomonas aeruginosa clinical isolate in Serbia.
    Lepsanovic Z; Libisch B; Tomanovic B; Nonkovici Z; Balogh B; Füzi M
    Acta Microbiol Immunol Hung; 2008 Dec; 55(4):447-54. PubMed ID: 19130752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.